Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value
$400.67M
Total Bought
$97.83M
Total Sold
$4.05B
Net Transaction
-$3.95B
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Rapport Therapeutics, Inc.(RAPP)02,498,051+2,498,051058,10514.50%+58,105
Contineum Therapeutics Inc.(CTNM)01,979,173+1,979,173034,8538.70%+34,853
Protagonist Therapeutics Inc.2,449,1832,449,183070,85584,86421.18%+14,009
Rallybio Corporation(RLYB)03,636,363+3,636,36304,8731.22%+4,873
Procept BioRobotics Corporation(PRCT)357,939357,939017,68921,8665.46%+4,177
Aldeyra Therapeutics, Inc.(ALDX)299,669299,66909809920.25%+12
Senseonics Holdings, Inc.(SENS)54,62154,621029220.01%-7
Tracon Pharmaceuticals, Inc.84,0030-84,003360—-36
BiomX Inc.(PHGE)1,923,2011,923,20108656460.16%-219
Clearside Biomedical, Inc.169,6290-169,6292600—-260
Standard BioTools Inc(LAB)311,967311,96708455520.14%-293
Nano-X Imaging Ltd.
ORD SHS
158,852158,85201,5521,1660.29%-386
Adicet Bio, Inc.364,472364,47208574410.11%-415
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,59807,0816,4351.61%-646
Vor Biopharma, Inc.(VOR)1,074,6581,074,65802,5471,0750.27%-1,472
Xencor, Inc.(XNCR)748,062748,062016,55514,1613.53%-2,394
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,445025,43018,1804.54%-7,250
Nanobiotix S.A.(NBTX)5,623,8165,623,816036,55428,1197.02%-8,435
Legend Biotech Corporation(LEGN)814,586814,586045,69036,0789.00%-9,612
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064040,31127,9596.98%-12,352
Fate Therapeutics, Inc.(FATE)3,379,0643,379,064024,80211,0832.77%-13,719
CVRx, Inc.(CVRX)4,103,4304,103,430074,72349,20012.28%-25,523
Shockwave Medical, Inc.166,8120-166,81254,3190—-54,319
Fusion Pharmaceuticals Inc.3,670,5160-3,670,51678,2550—-78,255
Kenvue Inc.(KVUE)182,329,5500-182,329,5503,912,7920—-3,912,792
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q2 2024 | TickerTrail